ESMO Open
ISSN: 2059-7029
Publisher: BMJ Publishing Group
Publications (22)
Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials (2020)
Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, Gaipl U
Journal article, Review article
Tolerability of BRAF/MEK inhibitor combinations: Adverse event evaluation and management (2019)
Heinzerling L, Eigentler TK, Fluck M, Hassel JC, Heller-Schenck D, Leipe J, Pauschinger M, et al.
Journal article, Review article